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Cardiogenic Shock

Kourtney J Crum, BSN, RN, CCRN, SRNA
Otterbein University, Westerville, Ohio
Pathophysiology
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Significance of
Pathophysiology

All types of shock
indicate a state of
multiorgan
dysfunction, the only
difference in shock
state is the initial
insult that caused this
shock state to occur

The primary cause is
acute myocardial
infarction causing a
downward spiral
It is imperative to
identify cardiogenic
shock and intervene
early to prevent endorgan failure

•

•

Image 1: Nagelhout & Elisha, 2018

What is cardiogenic
shock (CS)?
• End organ
hypoperfusion
related to a
significant
decrease in
cardiac output
due to a primary
cardiac diagnosis
(Mebazza et al.,
2018)

Clinical Classifications
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Image 2: Chioncel et al., 2020
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Why cardiogenic
shock?
• HIGH INCIDENCE OF
MORTALITY
• Approximately
100,000 cases per
year with 30-day
mortality
approaching 50%
(Brener et al., 2020)

CS occurs due to a
primary cardiac insult
leading to a disruption
in oxygen supply
CS leads to end-organ
failure because the
tissues are deprived of
oxygen because the
cardiac pump is no longer
functioning properly to
deliver oxygen
Etiologies: myocardial
infarction, ventricular
dysfunction, or valve
failure

Pre-CS:
• Identification early
• Hypoperfusion and SBP >
90mmHg without circulatory
support (Chioncel et al., 2020)
CS:
• Hypoperfusion and SBP <90
for >30min or the need for
pharmacologic or IABP (IntraAortic Balloon Pump) to
maintain SBP or MAP
(Chioncel et al., 2020)
Refractory CS:
• Ongoing tissue hypoperfusion
despite 2 vasopressor
medications and treatment of
initial etiology (Chioncel et
al., 2020)

Signs and Symptoms

Suggestive orRight Heart
Failu re

Lower limb edema
Sacral edema
Hepatomegaly
Increased jugular venous
distention
Regurgitant munnur in the
tricuspid area

Shared Findings

Cool peripheries
Cyanosis
Orthopnea
Delayed capillary refill

Figure 1: Vahdatpour et al., 2019

Suggestive of Left Heart
Failure

Lung crackles
Respiratory wheeze
Displaced cardiac apex
Left-sided heart murmurs

Nursing Implications
• Providing nursing education regarding
signs and symptoms, pathophysiology
and management options will allow
early intervention and help to decrease
the mortality rate
• Critical care nurses are with the
patients the majority of the time and is
their responsibility to notify the
physician with changes in patient
status

Mechanical Circulatory Support Devices
Impella

Image 3: Abiomed, 2021

The Impella device is
inserted into the left
ventricle and supports
left ventricular output
with the use of a motor
that unloads the left
ventricle increasing
cardiac output and end
organ perfusion
(Abiomed, 2021)

•

Critical Management
• Treatment options always focus on the
reversal of the underlying cause
whether it be valvular dysfunction,
acute myocardial infarction, ventricular
failure, or cardiac arrest

Pharmacological Treatment
• Fluid volume resuscitation should
considered if not contraindicated and
requires monitoring of cardiac output
as a state of hypervolemia could cause
worsening cardiogenic shock (Chioncel
et al., 2020)
• Persistent low cardiac output and
hypotension may require vasopressors
and inotropes. 80-90% of CS patients
receive pharmacological support
(Chioncel et al., 2020)
• Vasoactive medications should be
limited to short term use as they
increase myocardial oxygen
consumption and are complicated by
lethal arrythmias (Chioncel et al., 2020

Intra-Aortic Balloon
Pump (IABP)

•

Image 4: Kumar, 2017

•

•

Produces a significant
decreased afterload
and increased coronary
artery perfusion
Increases cardiac
output while
decreasing workload on
the heart

Mechanical cardiac devices are utilized short term
until surgical intervention or reversal of the initial
cause can be reversed

Conclusion
• Cardiogenic shock continues to have a high
mortality rate
• Prompt identification of the underlying cause is
imperative for the selection of treatment
• Management includes pharmacological and
mechanical support
• Future research should focus on a standard of care
to treat cardiogenic shock as it encompasses
numerous etiologies
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